Passionate, award-winning Marketing and Media Executive with an MBA and 15+ years success implementing cutting-edge strategies. Career highlights include driving development/launch of a groundbreaking e-Marketing branding initiative for Eli Lilly product Cialis that led to Website becoming #1 online pharma destination (and #1 in prescription conversions), increasing leads 30% and ROI 38% for $1B manufacturer Medtronic
Amarin’s clinical trial of fish oil may be tainted because of suspicions that the placebo group received mineral oil which could affect the absorption of statins. This “anti-statin” effect could raise “bad cholesterol” levels, enhancing the separation of major adverse cardiac events (MACE) between Vascepa and control.
Cardiologists who reviewed the data see a big problem with the study that could mean that it exaggerates Vascepa’s benefits.
Mineral oil may not not behaved as a placebo at all.
A new survey profiling how American adults’ access, use and feels about health-related information finds that most American social media users who regularly seek health information are concerned about incorrect or misleading medical information on social media, and few have found health information on social media to be accurate.
Two-thirds of American Healthcare Information Seekers (67 percent) report that they see health information on social media. The types of information they see on social media are mostly wellness advice (56 percent) and advertisements for treatments or medications (52 percent).
In 2018, the National Cancer Institute estimates there will be 1,735,000 new cases of cancer diagnosed in the U.S.
During the past 12 months, health care ads have reached 75% of U.S. cancer survivors on television, 54% at doctor’s offices and 40% via magazines.
When asked what sources of information they value the most, it’s no surprise that all survivors look primarily to their medical support team (doctors, nurses, pharmacists), medication packaging/labels and family/friends.